Schedule 13D ownership disclosure
AERPIO PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 00810B105
Event date: 2020-04-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,147,667
- Percent of class
- 7.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-049516
- Form type
- SC 13D
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Apr 22, 2020
- Reporting period
- Apr 21, 2020
- Description
- Schedule 13D beneficial ownership